Literature DB >> 27216060

Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.

Ammara Mushtaq1, Kerryl E Greenwood-Quaintance1, Nicolynn C Cole1, Peggy C Kohner1, Sherry M Ihde1, Gregory J Strand1, Lance W Harper1, Abinash Virk2, Robin Patel3.   

Abstract

MICs of 25 Abiotrophia defectiva and 109 Granulicatella adiacens isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of A. defectiva and G. adiacens isolates were, respectively, 24% and 34% to penicillin, 92% and 22% to ceftriaxone, 48% and 3% to cefepime, 72% and 87% to meropenem, 92% and 10% to cefotaxime, 100% and 97% to levofloxacin, 92% and 80% to clindamycin, and 24% and 50% to erythromycin. All isolates were susceptible to vancomycin. In the penicillin-susceptible subgroup, all A. defectiva isolates were susceptible to ceftriaxone; however, 62% of G. adiacens isolates were ceftriaxone nonsusceptible.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27216060      PMCID: PMC4958207          DOI: 10.1128/AAC.00485-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Abiotrophia defectiva: a rare cause of infective endocarditis.

Authors:  Mucahit Yemisen; Fatma Koksal; Bilgul Mete; Filiz Yarimcam; Baris Okcun; Serdar Kucukoglu; Mustafa Samasti; Bekir Kocazeybek; Recep Ozturk
Journal:  Scand J Infect Dis       Date:  2006

2.  Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.

Authors:  C K Murray; E A Walter; S Crawford; M L McElmeel; J H Jorgensen
Journal:  Clin Infect Dis       Date:  2001-04-18       Impact factor: 9.079

Review 3.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

Review 4.  Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  F Kate Gould; David W Denning; Tom S J Elliott; Juliet Foweraker; John D Perry; Bernard D Prendergast; Jonathan A T Sandoe; Michael J Spry; Richard W Watkin
Journal:  J Antimicrob Chemother       Date:  2011-11-14       Impact factor: 5.790

Review 5.  Endocarditis caused by nutritionally variant streptococci: a case report and literature review.

Authors:  Simone Giuliano; Roberta Caccese; Paolo Carfagna; Antonio Vena; Marco Falcone; Mario Venditti
Journal:  Infez Med       Date:  2012-06

6.  Case series of infective endocarditis caused by Granulicatella species.

Authors:  Eduardo Leal Adam; Rinaldo Focaccia Siciliano; Danielle Menosi Gualandro; Daniela Calderaro; Victor Sarli Issa; Flavia Rossi; Bruno Caramelli; Alfredo Jose Mansur; Tania Mara Varejao Strabelli
Journal:  Int J Infect Dis       Date:  2014-11-06       Impact factor: 3.623

Review 7.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 9.  Infective endocarditis due to Granulicatella adiacens: a case report and review.

Authors:  Kanne Padmaja; Vemu Lakshmi; Sreevdya Subramanian; Mamidi Neeraja; Siva Rama Krishna; O Sai Satish
Journal:  J Infect Dev Ctries       Date:  2014-04-15       Impact factor: 0.968

10.  Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans.

Authors:  Michael O Alberti; Janet A Hindler; Romney M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

View more
  4 in total

1.  Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates.

Authors:  Kunatum Prasidthrathsint; Mark A Fisher
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

2.  The Brief Case: A Variant on a Classic-Abiotrophia defectiva Endocarditis with Discitis.

Authors:  Rebekah E Dumm; Anna Wing; Aaron Richterman; Jerry Jacob; Laurel J Glaser; Kyle G Rodino
Journal:  J Clin Microbiol       Date:  2021-09-20       Impact factor: 5.948

3.  Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach.

Authors:  Cinzia Puzzolante; Gianluca Cuomo; Marianna Meschiari; Andrea Bedini; Aurora Bonazza; Claudia Venturelli; Mario Sarti; Cristina Mussini
Journal:  Case Rep Infect Dis       Date:  2019-05-06

4.  Development of High-Level Daptomycin Resistance in Abiotrophia and Granulicatella Species Isolates from Patients with Infective Endocarditis.

Authors:  María A Cañas; Adrian Téllez; Cristina García de la Mària; Anders Dahl; Javier García-González; Marta Hernández-Meneses; Manel Almela; Juan Ambrosioni; Carlos Falces; Eduard Quintana; Barbara Vidal; Andres Perissinotti; José M Tolosana; Elena Sandoval; Juan M Pericàs; Asunción Moreno; José M Miró
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.